SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-16-012262
Filing Date
2016-08-12
Accepted
2016-08-12 11:01:43
Documents
53
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm 10-Q/A 44925
  Complete submission text file 0001493152-16-012262.txt   6651754

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE rspi-20160630.xml EX-101.INS 1339476
3 XBRL SCHEMA FILE rspi-20160630.xsd EX-101.SCH 99522
4 XBRL CALCULATION FILE rspi-20160630_cal.xml EX-101.CAL 53060
5 XBRL DEFINITION FILE rspi-20160630_def.xml EX-101.DEF 385609
6 XBRL LABEL FILE rspi-20160630_lab.xml EX-101.LAB 649167
7 XBRL PRESENTATION FILE rspi-20160630_pre.xml EX-101.PRE 451356
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-16467 | Film No.: 161826833
SIC: 2834 Pharmaceutical Preparations